NKTX 241220 2.50P (NKTX241220P2500) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

NKTX241220P2500

Watchlist

0.14
0.000.00%

15min DelayTrading Dec 10 10:56 ET

0.00High0.00Low

Intraday

5D
Daily

News

Nkarta Opens Enrolment, Receives Clearance for Autoimmune Diseases Therapy Trials
MT NewswiresDec 5 07:17 ET
Nkarta's Ntrust-2 Trial of NKX019 in Myasthenia Gravis Begins Enrollment
TipRanksDec 5 06:15 ET
Express News | Nkarta Inc: Clinical Data From Ntrust-1 and Ntrust-2 Planned for 2025
ReutersDec 5 06:01 ET
Express News | Nkarta Announces Ind Clearance of Investigator-Sponsored Trial in Myasthenia Gravis and Opening of Enrollment for Ntrust-2
ReutersDec 5 06:01 ET
Nkarta Announces IND Clearance of Investigator-Sponsored Trial in Myasthenia Gravis and Opening of Enrollment for Ntrust-2
NkartaDec 5 00:00 ET
Nkarta to Participate in an Upcoming Investor Conference
NkartaNov 26 00:00 ET

Comments

70205719

20 hours ago

$Nkarta (NKTX.US)$
morning star? bottom now with big vol. buy now?

Jaguar8

Dec 5 05:09

NEWS

$Nkarta (NKTX.US)$
Nkarta Announces IND Clearance of Investigator-Sponsored Trial in Myasthenia Gravis and Opening of Enrollment for Ntrust-2
Nkarta (NKTX) announced the opening of enrollment for Ntrust-2 and IND clearance for an investigator-sponsored trial (IST) evaluating NKX019, their allogeneic CD19-directed CAR NK-cell therapy. Ntrust-2 will evaluate the treatment across three parallel cohorts: systemic sclerosis, myositis, and ANCA-associated vasculitis. The IST will study NKX019 in my...

Trytosaveabit

Dec 5 05:04

News

$Nkarta (NKTX.US)$ Reuters· 2 mins ago
Nkarta Announces Ind Clearance of Investigator-Sponsored Trial in Myasthenia Gravis and Opening of Enrollment for Ntrust-2

iamiam

Nov 11 09:54

$Nkarta (NKTX.US)$
boom boom boom boom 💥 getting richer from my room 🤣
$Nkarta (NKTX.US)$
$Nkarta (NKTX.US)$

Unsupported feature. Please use the mobile app.

Share Your Profit/Loss

iamiam

Oct 31 00:15

$Nkarta (NKTX.US)$
I don't know why I didn't share it in my previous post or why I just thought to share it now 🤷🏽 but here we go. this is what I shared with the group.
I know i said not to buy ibrx because it was too volatile. I've changed my tune because of my biopharma outlook.... want it's twin?
cancer killing cell developer, starting with leukemia! buy rating at 17 (i think it pops to 23, but 19 is the full extension) 👌
see that daily turnaround? that's a bottom
see the accumulation at th...

Unsupported feature. Please use the mobile app.